Trilogy Capital Inc. Johnson & Johnson Transaction History
Trilogy Capital Inc.
- $1.92 Billion
- Q3 2024
A detailed history of Trilogy Capital Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Trilogy Capital Inc. holds 5,144 shares of JNJ stock, worth $746,137. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,144
Previous 4,949
3.94%
Holding current value
$746,137
Previous $723,000
15.21%
% of portfolio
0.04%
Previous 0.04%
Shares
19 transactions
Others Institutions Holding JNJ
# of Institutions
4,275Shares Held
1.68BCall Options Held
17.6MPut Options Held
14.5M-
Vanguard Group Inc Valley Forge, PA231MShares$33.5 Billion0.69% of portfolio
-
Black Rock Inc. New York, NY198MShares$28.7 Billion0.67% of portfolio
-
State Street Corp Boston, MA134MShares$19.5 Billion0.9% of portfolio
-
Geode Capital Management, LLC Boston, MA56.1MShares$8.14 Billion0.75% of portfolio
-
Morgan Stanley New York, NY45.2MShares$6.55 Billion0.54% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $379B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...